CoChat

The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.

Highly efficient intercellular spreading of protein misfolding mediated by viral ligand-receptor interactions

Open access

Published version of a preprint

Abstract

Protein aggregates associated with neurodegenerative diseases have the ability to transmit to unaffected cells, thereby templating their own aberrant conformation onto soluble homotypic proteins. Proteopathic seeds can be released into the extracellular space, secreted in association with extracellular vesicles (EV) or exchanged by direct cell-to-cell contact. The extent to which each of these pathways contribute to the prion-like spreading of protein misfolding is unclear. Exchange of cellular cargo by both direct cell contact or via EV depends on receptor-ligand interactions. We hypothesized that enabling these interactions through viral ligands enhances intercellular proteopathic seed transmission. Using different cellular models propagating prions or pathogenic Tau aggregates, we demonstrate that vesicular stomatitis virus glycoprotein and SARS-CoV-2 spike S increase aggregate induction by cell contact or ligand-decorated EV. Thus, receptor-ligand interactions are important determinants of intercellular aggregate dissemination. Our data raise the possibility that viral infections contribute to proteopathic seed spreading by facilitating intercellular cargo transfer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-021-25855-2

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 VSV-G expression by donor cells increases induction of Sup35 NM prions in cocultured recipient cells. a A HEK NM-HAagg cell clone and a N2a NM-HAagg clone (red) with poor aggregate-inducing activity in recipients were chosen as donors (Do.). Donor cells were transiently transfected with plasmid coding for VSV-G or Mock transfected and cocultured with recipient cells expressing NM-GFPsol (Re.). b Transfected donor cells cocultured with recipient cells. Do Donor Re Recipient. NM-HA was stained using anti-HA antibodies. c–f Quantitative analysis of the percentage of recipient cells with induced NM-GFP aggregates (NM-GFPagg). g Cell surface expression of VSV-G in donor HEK NM-HAagg cells. Cells were fixed 24 h post transfection (VSV-G antibody 8GF11). Insets show individual cells. h. Transfection efficiency in HEK NM-HAagg cells. Shown is the percentage of cells expressing VSV-G. i. VSV-G (WT) or VSV-G mutant transfected donor cells were cocultured with recipient HEK NM-GFPsol cells. NM-GFP aggregate induction was determined 1-day post coculture. Induction rates related to WT VSV-G expression were set to 100 %. All data are shown as the means ± SD from four (h) or six (c–f, i) replicate cell cultures. Three (c–f, h, i) independent experiments were carried out with similar results. P values were calculated by two-tailed unpaired Student´s t test (c–f) or one-way ANOVA (h, i). Source data are provided as a Source Data file.
Fig. 1 VSV-G expression by donor cells increases induction of Sup35 NM prions in cocultured recipient cells. a A HEK NM-HAagg cell clone and a N2a NM-HAagg clone (red) with poor aggregate-inducing activity in recipients were chosen as donors (Do.). Donor cells were transiently transfected with plasmid coding for VSV-G or Mock transfected and cocultured with recipient cells expressing NM-GFPsol (Re.). b Transfected donor cells cocultured with recipient cells. Do Donor Re Recipient. NM-HA was stained using anti-HA antibodies. c–f Quantitative analysis of the percentage of recipient cells with induced NM-GFP aggregates (NM-GFPagg). g Cell surface expression of VSV-G in donor HEK NM-HAagg cells. Cells were fixed 24 h post transfection (VSV-G antibody 8GF11). Insets show individual cells. h. Transfection efficiency in HEK NM-HAagg cells. Shown is the percentage of cells expressing VSV-G. i. VSV-G (WT) or VSV-G mutant transfected donor cells were cocultured with recipient HEK NM-GFPsol cells. NM-GFP aggregate induction was determined 1-day post coculture. Induction rates related to WT VSV-G expression were set to 100 %. All data are shown as the means ± SD from four (h) or six (c–f, i) replicate cell cultures. Three (c–f, h, i) independent experiments were carried out with similar results. P values were calculated by two-tailed unpaired Student´s t test (c–f) or one-way ANOVA (h, i). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 2 Pseudotyping EV with VSV-G drastically increases their intercellular NM aggregate induction efficiency. a HEK or N2a NM-HAagg donors (Do.) were transfected with VSV-G coding plasmid or empty vector. Recipient (Re.) HEK or N2a cells expressing NM-GFPsol were exposed to EV. b Transmission electron microscopy images of EV isolated from transfected HEK NM-HAagg donor cells. c Western blot of EV lysates. d Percentage of recipient HEK NM-GFP cells with induced NM-GFP aggregates upon exposure to EV. Sonication (5 min, 100 % power) was used to destroy EV. e. Particle numbers of EV from VSV-G transfected or Mock transfected donors determined 3-day post transfection. f Size distribution of different EV. g. EV preparations adjusted to comparable EV numbers were added to recipient N2a NM-GFPsol cells. Recipient cells were analyzed for the percentage of cells with induced NM-GFP aggregates. h Human astrocytes expressing NM-GFPsol were exposed to VSV-G-pseudotyped or non-pseudotyped EV. NM-GFP aggregate induction was monitored 2-day post EV exposure. i. Astrocytes exposed to EV from HEK cells harboring NM-HAagg. Arrowhead depicts aggregated NM-GFP. j Percentage of astrocytes with NM-GFPagg following exposure to EV from transfected donors. k Astrocytes were transduced with lentivirus coding for NM-HA. Cells were subsequently exposed to VSV-G-pseudotyped EV from HEK NM-HAagg cells to generate a donor population with a high percentage of NM-HAagg astrocytes. Donors were transduced with Mock lentivirus or VSV-G-coding lentivirus. EV harvested after medium exchange and adjusted to comparable particle numbers were added to HEK cells expressing NM-GFPsol. l HEK NM-GFPsol cells 24 h postexposure to VSV-G or Mock EV harvested from astrocytes. m. Percentage of HEK cells with induced NM-GFP aggregates upon exposure to astrocyte EV. All data are shown as the means ± SD from three (d, j, m) or six (e, g) replicate cell cultures. Three (d, e, g, j) independent experiments were carried out with similar results. Experiment (m) was carried out once with three independent cell cultures per group. P values were calculated by two-tailed unpaired Student´s t test (e, g, j) or one-way ANOVA (d, m). Source data are provided as a Source Data file.
Fig. 2 Pseudotyping EV with VSV-G drastically increases their intercellular NM aggregate induction efficiency. a HEK or N2a NM-HAagg donors (Do.) were transfected with VSV-G coding plasmid or empty vector. Recipient (Re.) HEK or N2a cells expressing NM-GFPsol were exposed to EV. b Transmission electron microscopy images of EV isolated from transfected HEK NM-HAagg donor cells. c Western blot of EV lysates. d Percentage of recipient HEK NM-GFP cells with induced NM-GFP aggregates upon exposure to EV. Sonication (5 min, 100 % power) was used to destroy EV. e. Particle numbers of EV from VSV-G transfected or Mock transfected donors determined 3-day post transfection. f Size distribution of different EV. g. EV preparations adjusted to comparable EV numbers were added to recipient N2a NM-GFPsol cells. Recipient cells were analyzed for the percentage of cells with induced NM-GFP aggregates. h Human astrocytes expressing NM-GFPsol were exposed to VSV-G-pseudotyped or non-pseudotyped EV. NM-GFP aggregate induction was monitored 2-day post EV exposure. i. Astrocytes exposed to EV from HEK cells harboring NM-HAagg. Arrowhead depicts aggregated NM-GFP. j Percentage of astrocytes with NM-GFPagg following exposure to EV from transfected donors. k Astrocytes were transduced with lentivirus coding for NM-HA. Cells were subsequently exposed to VSV-G-pseudotyped EV from HEK NM-HAagg cells to generate a donor population with a high percentage of NM-HAagg astrocytes. Donors were transduced with Mock lentivirus or VSV-G-coding lentivirus. EV harvested after medium exchange and adjusted to comparable particle numbers were added to HEK cells expressing NM-GFPsol. l HEK NM-GFPsol cells 24 h postexposure to VSV-G or Mock EV harvested from astrocytes. m. Percentage of HEK cells with induced NM-GFP aggregates upon exposure to astrocyte EV. All data are shown as the means ± SD from three (d, j, m) or six (e, g) replicate cell cultures. Three (d, e, g, j) independent experiments were carried out with similar results. Experiment (m) was carried out once with three independent cell cultures per group. P values were calculated by two-tailed unpaired Student´s t test (e, g, j) or one-way ANOVA (d, m). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 3 VSV-G-pseudotyped EV are preferentially taken up by clathrin-mediated endocytosis. a Kinetics of EV-mediated NM-GFP aggregate induction. HEK NM-GFPsol cells were exposed to EV from HEK NM-HAagg cells transfected with VSV-G plasmid. Life cell imaging was initiated immediately after EV exposure. Arrowhead depicts aggregate. b HEK NM-GFPsol cells were transfected with control siRNA or siRNA against clathrin heavy chain CLTC. 72 h later, cells were exposed to VSV-G-pseudotyped EV from HEK NM-HAagg donors. Cells were assessed for EV uptake 1 h post EV exposure. c Western blot of CLTC knock-down 72 h post transfection. d Quantitative analysis of CLTC knock-down. e Detection of VSV-G and NM-HA 1 h post EV addition. f Recipient HEK NM-GFPsol cells were transfected with CLTC or control siRNA and 72 h later exposed to EV for 4 or 24 h. g, h Percentages of CLTC siRNA transfected recipients with NM-GFPagg compared to induced recipient cells transfected with control siRNA set to 100 %. Cells were imaged 4 (g) and 24 h (h) post EV exposure. i Recipient cells were exposed to inhibitors for 1–2 h and aggregate induction was monitored either 4 or 24 h post EV exposure. Baf Bafilomycin, CQ Chloroquine, Dyn Dynasore, Api Apilimod. j, k Percentages of drug-treated recipients with NM-GFPagg compared to recipients treated with DMSO set to 100%. Recipient cells with NM-GFPagg were analyzed 4 h (j) or 24 h (k) post EV addition. All data are shown as the means ± SD from three (d, g, h, j, k) replicate cell cultures. Three independent experiments were carried out with similar results (d). EV experiments with CLTC knock-down or drug treatment were performed once at 4 h and once at 24 h (g, h, j, k). P values calculated by two-tailed unpaired Student´s t test (d, g, h) or one-way ANOVA (j, k). ns nonsignificant. Source data are provided as a Source Data file.
Fig. 3 VSV-G-pseudotyped EV are preferentially taken up by clathrin-mediated endocytosis. a Kinetics of EV-mediated NM-GFP aggregate induction. HEK NM-GFPsol cells were exposed to EV from HEK NM-HAagg cells transfected with VSV-G plasmid. Life cell imaging was initiated immediately after EV exposure. Arrowhead depicts aggregate. b HEK NM-GFPsol cells were transfected with control siRNA or siRNA against clathrin heavy chain CLTC. 72 h later, cells were exposed to VSV-G-pseudotyped EV from HEK NM-HAagg donors. Cells were assessed for EV uptake 1 h post EV exposure. c Western blot of CLTC knock-down 72 h post transfection. d Quantitative analysis of CLTC knock-down. e Detection of VSV-G and NM-HA 1 h post EV addition. f Recipient HEK NM-GFPsol cells were transfected with CLTC or control siRNA and 72 h later exposed to EV for 4 or 24 h. g, h Percentages of CLTC siRNA transfected recipients with NM-GFPagg compared to induced recipient cells transfected with control siRNA set to 100 %. Cells were imaged 4 (g) and 24 h (h) post EV exposure. i Recipient cells were exposed to inhibitors for 1–2 h and aggregate induction was monitored either 4 or 24 h post EV exposure. Baf Bafilomycin, CQ Chloroquine, Dyn Dynasore, Api Apilimod. j, k Percentages of drug-treated recipients with NM-GFPagg compared to recipients treated with DMSO set to 100%. Recipient cells with NM-GFPagg were analyzed 4 h (j) or 24 h (k) post EV addition. All data are shown as the means ± SD from three (d, g, h, j, k) replicate cell cultures. Three independent experiments were carried out with similar results (d). EV experiments with CLTC knock-down or drug treatment were performed once at 4 h and once at 24 h (g, h, j, k). P values calculated by two-tailed unpaired Student´s t test (d, g, h) or one-way ANOVA (j, k). ns nonsignificant. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 4 VSV-G expression enhances Tau aggregate induction. a HEK Tau-GFP population and HEK clones propagating aggregated Tau-GFP. A HEK cell clone expressing soluble Tau-GFP (HEK Tau-GFPsol) was exposed to 1% brain homogenates from tauopathy patients. Clones with visible Tau-GFP foci were isolated (Tau-GFPAD, Tau-GFPFTLD, Tau-GFPPSP, Tau-GFPCBD). Arrowheads: Tau-GFP foci. b Sedimentation assay of cell lysates from HEK Tau-GFPsol cells and clones propagating Tau-GFPagg. T: total cell lysate; P: pellet; S: supernatant. c Transfected HEK Tau-GFPagg clones were cocultured with HEK cells stably expressing soluble Tau-FusionRed (HEK Tau-FRsol). d Transfected HEK Tau-GFPAD cells were cocultured with recipient cells. Foci were monitored 2-day post coculture. Arrow: Tau-FR foci. e Percentage of cocultured recipient cells with induced Tau-FR foci. f Western blot of EV. g Sedimentation assay of Tau in EV (anti-Tau antibody ab64193). h EV from transfected donors were added to HEK Tau-FRsol cells. i Exposure of HEK Tau-FRsol cells to EV from transfected HEK Tau-GFPAD. j Percentage of recipient cells with induced Tau-FR foci following EV addition. EV were also subjected to sonication (5 min, 100 % power). k Size distribution of EV. l EV released from transfected HEK Tau-GFPAD or Tau-GFPCBD donors were determined 3-day post transfection. m EV adjusted to comparable particle numbers were added to HEK Tau-FRsol cells. Cells with induced TauFRagg were determined 2 days later. All data are shown as the means ± SD from three (j), six (e), or nine (l, m) replicate cell cultures. Three (e, j, l, m) independent experiments were carried out with similar results. P values calculated by two-tailed unpaired Student´s t test (e, l, m) or one-way ANOVA (j). Source data are provided as a Source Data file.
Fig. 4 VSV-G expression enhances Tau aggregate induction. a HEK Tau-GFP population and HEK clones propagating aggregated Tau-GFP. A HEK cell clone expressing soluble Tau-GFP (HEK Tau-GFPsol) was exposed to 1% brain homogenates from tauopathy patients. Clones with visible Tau-GFP foci were isolated (Tau-GFPAD, Tau-GFPFTLD, Tau-GFPPSP, Tau-GFPCBD). Arrowheads: Tau-GFP foci. b Sedimentation assay of cell lysates from HEK Tau-GFPsol cells and clones propagating Tau-GFPagg. T: total cell lysate; P: pellet; S: supernatant. c Transfected HEK Tau-GFPagg clones were cocultured with HEK cells stably expressing soluble Tau-FusionRed (HEK Tau-FRsol). d Transfected HEK Tau-GFPAD cells were cocultured with recipient cells. Foci were monitored 2-day post coculture. Arrow: Tau-FR foci. e Percentage of cocultured recipient cells with induced Tau-FR foci. f Western blot of EV. g Sedimentation assay of Tau in EV (anti-Tau antibody ab64193). h EV from transfected donors were added to HEK Tau-FRsol cells. i Exposure of HEK Tau-FRsol cells to EV from transfected HEK Tau-GFPAD. j Percentage of recipient cells with induced Tau-FR foci following EV addition. EV were also subjected to sonication (5 min, 100 % power). k Size distribution of EV. l EV released from transfected HEK Tau-GFPAD or Tau-GFPCBD donors were determined 3-day post transfection. m EV adjusted to comparable particle numbers were added to HEK Tau-FRsol cells. Cells with induced TauFRagg were determined 2 days later. All data are shown as the means ± SD from three (j), six (e), or nine (l, m) replicate cell cultures. Three (e, j, l, m) independent experiments were carried out with similar results. P values calculated by two-tailed unpaired Student´s t test (e, l, m) or one-way ANOVA (j). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 5 VSV-G increases spreading of transmissible spongiform encephalopathy agent. a EV from transfected N2a cells persistently infected with scrapie strain 22 L (N2a22L) were added to prion-permissive CAD5 or L929 cells. Recipient cells were passaged 7–8 times before PrPSc formation was monitored. b Western blot of EV from donor cells. c Exposure of recipient cells to VSV-G-pseudotyped EV leads to infection. GAPDH and total PrP were detected on one blot (passage 7). Note that PrPC and PrPSc run as unglycosylated, mono-glycosylated, and di-glycosylated bands. Total PrP refers to both the PrPC and PrPSc. Glycosylation profiles of PrPC and PrPSc differ90. Nine times more PrPSc sample was loaded. d Detection of PrPSc in recipient cells exposed to EV from scrapie-infected donor cells eight passages postinfection. Arrowheads: PrPSc. e, f Quantitative analyses of recipients with PrPSc puncta following exposure to EV from transfected donors. g Particles released from transfected N2a22L cells. h Western blot demonstrating PK-resistant PrPSc. EV were adjusted to comparable particles numbers before addition to cells. Cells were analyzed four passages postinfection. Note that by then EV have been diluted out 104 times. Loading as above. i Quantitative analyses of the presence of PrPSc in L929 cells exposed to VSV-G-decorated EV as in (e). Cells were analyzed 8 passages postinfection. All data are shown as the means ± SD from three (e–g) or six (i) replicate cell cultures. Three (e–g, i) independent experiments were carried out with similar results. P values calculated by two-tailed unpaired Student´s t test (e–g, i). Source data are provided as a Source Data file.
Fig. 5 VSV-G increases spreading of transmissible spongiform encephalopathy agent. a EV from transfected N2a cells persistently infected with scrapie strain 22 L (N2a22L) were added to prion-permissive CAD5 or L929 cells. Recipient cells were passaged 7–8 times before PrPSc formation was monitored. b Western blot of EV from donor cells. c Exposure of recipient cells to VSV-G-pseudotyped EV leads to infection. GAPDH and total PrP were detected on one blot (passage 7). Note that PrPC and PrPSc run as unglycosylated, mono-glycosylated, and di-glycosylated bands. Total PrP refers to both the PrPC and PrPSc. Glycosylation profiles of PrPC and PrPSc differ90. Nine times more PrPSc sample was loaded. d Detection of PrPSc in recipient cells exposed to EV from scrapie-infected donor cells eight passages postinfection. Arrowheads: PrPSc. e, f Quantitative analyses of recipients with PrPSc puncta following exposure to EV from transfected donors. g Particles released from transfected N2a22L cells. h Western blot demonstrating PK-resistant PrPSc. EV were adjusted to comparable particles numbers before addition to cells. Cells were analyzed four passages postinfection. Note that by then EV have been diluted out 104 times. Loading as above. i Quantitative analyses of the presence of PrPSc in L929 cells exposed to VSV-G-decorated EV as in (e). Cells were analyzed 8 passages postinfection. All data are shown as the means ± SD from three (e–g) or six (i) replicate cell cultures. Three (e–g, i) independent experiments were carried out with similar results. P values calculated by two-tailed unpaired Student´s t test (e–g, i). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 6 SARS-CoV-2 spike S protein affects spreading of proteopathic seeds. a. HEK NM-HAagg or Tau-GFPagg cells, transfected with plasmid coding for CoV-2 spike S or Mock transfected, were cocultured with respective recipient HEK cells overexpressing/not overexpressing human ACE2. Alternatively, donors were cocultured with Vero cells stably expressing NM-GFPsol or Tau-FRsol. b Expression of CoV-2 spike S in donor HEK cells. c Cocultures of transfected HEK NM-HAagg donors and recipient Vero NM-GFPsol cells. d Cocultures of transfected donor HEK Tau-GFPAD cells with recipient Vero Tau-FRsol cells. e Western blot of recipient HEK cells expressing ACE2-Flag. The blot was probed with anti-ACE2 antibodies. f–h Percentage of recipients with induced aggregates. i Presence of spike S on EV. j EV from donors transfected with empty or spike S plasmid were added to Vero cells. The percentage of recipients with induced aggregates was assessed 2 days later. k Particle numbers. l, m Percentage of EV exposed recipients with induced aggregates All data are shown as the means ± SD from three (l, m) or six (f–h, k) replicate cell cultures. Two (f–h, k–m) independent experiments were carried out with similar results. P values calculated by two-tailed unpaired Student´s t test (k–m) or one-way ANOVA (f–h). ns nonsignificant. Source data are provided as a Source Data file.
Fig. 6 SARS-CoV-2 spike S protein affects spreading of proteopathic seeds. a. HEK NM-HAagg or Tau-GFPagg cells, transfected with plasmid coding for CoV-2 spike S or Mock transfected, were cocultured with respective recipient HEK cells overexpressing/not overexpressing human ACE2. Alternatively, donors were cocultured with Vero cells stably expressing NM-GFPsol or Tau-FRsol. b Expression of CoV-2 spike S in donor HEK cells. c Cocultures of transfected HEK NM-HAagg donors and recipient Vero NM-GFPsol cells. d Cocultures of transfected donor HEK Tau-GFPAD cells with recipient Vero Tau-FRsol cells. e Western blot of recipient HEK cells expressing ACE2-Flag. The blot was probed with anti-ACE2 antibodies. f–h Percentage of recipients with induced aggregates. i Presence of spike S on EV. j EV from donors transfected with empty or spike S plasmid were added to Vero cells. The percentage of recipients with induced aggregates was assessed 2 days later. k Particle numbers. l, m Percentage of EV exposed recipients with induced aggregates All data are shown as the means ± SD from three (l, m) or six (f–h, k) replicate cell cultures. Two (f–h, k–m) independent experiments were carried out with similar results. P values calculated by two-tailed unpaired Student´s t test (k–m) or one-way ANOVA (f–h). ns nonsignificant. Source data are provided as a Source Data file.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 124 references

Cited by

See all 81

Metadata

Authors
Liu, S., Hossinger, A., Heumüller, S.-E., Hornberger, A., Buravlova, O., Konstantoulea, K., Müller, S. A., Paulsen, L., Rousseau, F., Schymkowitz, J., Lichtenthaler, S. F., Neumann, M., Denner, P., & Vorberg, I. M.
Affiliations
  • German Federal Institute for Risk Assessment (BfR) (DE)
  • German Center for Neurodegenerative Diseases (DE)
  • VIB-KU Leuven Center for Brain & Disease Research (BE)
  • University of Bonn (DE)
Corresponding author
Vorberg, Ina M.
Venue
Nature Communications
Published
2021-10-19
Volume
12
Issue
1
Pages
5739-5739
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3206451123
Cited by
72
References
124
Citations by year
2026: 5 · 2025: 4 · 2024: 13 · 2023: 18 · 2022: 30 · 2021: 2
FWCI
4.94
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lirias (submittedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion, cc-by)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
  • DZNE Pub (submittedVersion, other-oa)
Funders
  • Deutsche Forschungsgemeinschaft (EXC 2145, EXC 2145SyNergy, 390857198)
  • Fonds Wetenschappelijk Onderzoek (C0401, G045920N, G0H1716N, I011620N)
  • KU Leuven (C0401)
  • Vlaams Instituut voor Biotechnologie (C0401)
  • Deutsches Zentrum für Neurodegenerative Erkrankungen
  • Vlaamse regering
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
protein misfolding, prion-like spreading, extracellular vesicles, vesicular stomatitis virus glycoprotein, SARS-CoV-2 spike protein, tau aggregates, neurodegenerative diseases, protein aggregates, cell-cell contact, viral infection
MeSH terms
Extracellular Vesicles, Intravital Microscopy, Angiotensin-Converting Enzyme 2, Adult, Aged, Brain, Cell Line, Endocytosis, Female, Humans, Male, Membrane Glycoproteins, Middle Aged, Prions, Viral Envelope Proteins, Case-Control Studies, tau Proteins, Protein Folding, Spike Glycoprotein, Coronavirus, Protein Aggregation, Pathological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Highly efficient intercellular spreading of protein misfolding mediated by viral ligand-receptor interactions. https://app.cochat.ai/papers/10.1038/s41467-021-25855-2
The paper
Liu, S., Hossinger, A., Heumüller, S.-E., Hornberger, A., Buravlova, O., Konstantoulea, K., Müller, S. A., Paulsen, L., Rousseau, F., Schymkowitz, J., Lichtenthaler, S. F., Neumann, M., Denner, P., & Vorberg, I. M. (2021). Highly efficient intercellular spreading of protein misfolding mediated by viral ligand-receptor interactions. Nature Communications. https://doi.org/10.1038/s41467-021-25855-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.